AGP Executive Report
Last update: 6 hours agoUS-Canada Trade War: President Donald Trump has imposed 50% tariffs on most Canadian goods, citing “continued discrimination” over autos, alcohol and dairy; the White House says the move starts in 30 days, with energy, potash, fish and critical minerals excluded, raising fears of higher inflation and a wider trade conflict. Swiss Pharma Deal Watch: Samsung Biologics plans to buy Swiss peptide maker PolyPeptide for about $1.8bn in cash, aiming to expand into peptide therapeutics and GLP-1 manufacturing capacity. AI Cost Pressure on SMEs: Small businesses relying on generative AI are seeing subscription prices jump sharply and new “agent” features drive bills up fast, pushing some trainers to recommend spreading risk with smaller local open-source models. Swiss Consumer Price Reality Check: A Deutsche Bank price mapping study puts Zurich and Geneva among the world’s priciest cities for a McMeal, highlighting Switzerland’s cost-of-living squeeze. Swiss Business & Economy: Austria’s export data show Upper Austria remains the export powerhouse despite 2025 headwinds, while river cruise operators across Europe are rerouting due to drought and record heat affecting the Rhine and Danube. Local Swiss Angle: Zurich is testing a new approach to drug-crisis response amid a surge in crack cocaine use, as authorities face pressure to adapt quickly.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
